$LLY Cashflow Statement | Understand Stock

$LLY

$1,279.44 +$5.98 (0.47%) Live

$LLY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities
Net income
Adjustments to Reconcile Net Income to Cash Flows from Operating Activities:
Gain related to disposition of Elanco (Note 19)
Gain on sale of antibiotic business in China (Note 3)
Depreciation and amortization
Debt extinguishment loss (Note 11)
Change in deferred income taxes
Stock-based compensation expense
Investment (gains) losses, net
Acquired in-process research and development and development milestones (Note 3)
Gains on sale of product rights
Acquired in-process research and development
Other operating activities, net
Other changes in operating assets and liabilities, net of acquisitions and divestitures:
Receivables—(increase) decrease
Inventories—(increase) decrease
Other assets—(increase) decrease
Income taxes payable—increase (decrease)
Prepaid expenses and other assets—(increase) decrease
Accounts payable and other liabilities—increase (decrease)

Net Cash Provided by Operating Activities
Cash Flows from Investing Activities
Purchases of property and equipment
Proceeds from sales and maturities of short-term investments
Purchases of short-term investments
Proceeds from sales of and distributions from noncurrent investments
Purchases of noncurrent investments
Cash distributed to Elanco upon disposition
Cash received for sale of antibiotic business in China
Proceeds from sale of product rights
Purchases of in-process research and development
Cash paid for acquisitions, net of cash acquired
Other investing activities, net
Net Cash Used for Investing Activities

Cash Flows from Financing Activities
Dividends paid
Net change in short-term borrowings
Proceeds from issuance of long-term debt
Repayments of long-term debt
Purchases of common stock
Other financing activities, net
Net Cash Provided by (Used for) Financing Activities
Effect of exchange rate changes on cash and cash equivalents
Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and Cash Equivalents at End of Year

Comments